Showing results (241-250 of 516) with videos related to
Sort By:
Pageof 52
British Journal of Cancer|June 11, 1999
Double-blind randomized study on the myeloprotective effect of melatonin in combination with carboplatin and etoposide in advanced lung cancerM Ghielmini, O Pagani, J de Jong, et al.The Journal of Biological Chemistry|April 27, 2000
Reconstitution of an endothelial nitric-oxide synthase (eNOS), hsp90, and caveolin-1 complex in vitro. Evidence that hsp90 facilitates calmodulin stimulated displacement of eNOS from caveolin-1J P Gratton, J Fontana, D S O'Connor, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 1991
Phase II studies of 4'-iodo-4'-deoxydoxorubicin in advanced non-small cell lung, colon and breast cancersC Sessa, F Calabresi, F Cavalli, et al.Biochemical and Biophysical Research Communications|January 8, 2013
eNOS phosphorylation on serine 1176 affects insulin sensitivity and adipositySatoshi Kashiwagi, Dmitriy N Atochin, Qian Li, et al.The Journal of Biological Chemistry|March 30, 2001
The sonic hedgehog receptor patched associates with caveolin-1 in cholesterol-rich microdomains of the plasma membraneH E Karpen, J T Bukowski, T Hughes, et al.Gastroenterology|October 27, 1999
Impaired endothelial nitric oxide synthase activity associated with enhanced caveolin binding in experimental cirrhosis in the ratV Shah, M Toruner, F Haddad, et al.The Journal of Biological Chemistry|May 12, 2004
Targeting of endothelial nitric-oxide synthase to the cytoplasmic face of the Golgi complex or plasma membrane regulates Akt- versus calcium-dependent mechanisms for nitric oxide releaseDavid Fulton, Roger Babbitt, Stefan Zoellner, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1988
Phase II study of iproplatin in advanced ovarian carcinomaC Sessa, J Vermorken, J Renard, et al.Elife|April 28, 2021
eNOS-induced vascular barrier disruption in retinopathy by c-Src activation and tyrosine phosphorylation of VE-cadherinTakeshi Ninchoji, Dominic T Love, Ross O Smith, et al.Nature Medicine|September 6, 2000
The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animalsY Kureishi, Z Luo, I Shiojima, et al.Pageof 52